|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
2004-11-3
|
|
pubmed:abstractText |
To determine whether an intravitreal injection of triamcinolone acetonide for persistent diabetic macular edema after adequate laser treatment improves visual acuity.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
1549-4713
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
111
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2044-9
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15522370-Aged,
pubmed-meshheading:15522370-Diabetic Retinopathy,
pubmed-meshheading:15522370-Double-Blind Method,
pubmed-meshheading:15522370-Female,
pubmed-meshheading:15522370-Glucocorticoids,
pubmed-meshheading:15522370-Humans,
pubmed-meshheading:15522370-Injections,
pubmed-meshheading:15522370-Laser Coagulation,
pubmed-meshheading:15522370-Macular Edema,
pubmed-meshheading:15522370-Male,
pubmed-meshheading:15522370-Prospective Studies,
pubmed-meshheading:15522370-Safety,
pubmed-meshheading:15522370-Treatment Failure,
pubmed-meshheading:15522370-Treatment Outcome,
pubmed-meshheading:15522370-Triamcinolone Acetonide,
pubmed-meshheading:15522370-Visual Acuity,
pubmed-meshheading:15522370-Vitreous Body
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
|
|
pubmed:affiliation |
Save Sight Institute, Department of Clinical Ophthalmology and Eye Health, The University of Sydney, Sydney, NSW, Australia.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
